[Tc-99m]-sestamibi uptake and washout in locally advanced breast cancer are correlated with tumor blood flow.

[1]  Robert B Livingston,et al.  Blood flow and metabolism in locally advanced breast cancer: relationship to response to therapy. , 2002, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[2]  D. Mankoff,et al.  Monitoring the response of patients with locally advanced breast carcinoma to neoadjuvant chemotherapy using [technetium 99m]‐sestamibi scintimammography , 1999, Cancer.

[3]  T. Leitha,et al.  Is early sestamibi imaging in head and neck cancer affected by MDR status, p53 expression, or cell proliferation? , 1998, Nuclear medicine and biology.

[4]  J. Taki,et al.  Assessment of P-glycoprotein in patients with malignant bone and soft-tissue tumors using technetium-99m-MIBI scintigraphy. , 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[5]  D. Mankoff,et al.  Kinetic analysis of 2-[carbon-11]thymidine PET imaging studies: compartmental model and mathematical analysis. , 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[6]  L. Kostakoglu,et al.  Influence of the heterogeneity of P-glycoprotein expression on technetium-99m-MIBI uptake in breast cancer. , 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[7]  R. Thomas,et al.  Tumor clearance of technetium 99m-sestamibi as a predictor of response to neoadjuvant chemotherapy for locally advanced breast cancer. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[8]  S. Emri,et al.  Association of tumor washout rates and accumulation of technetium-99m-MIBI with expression of P-glycoprotein in lung cancer. , 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[9]  H. Bom,et al.  Technetium-99m-MIBI uptake in small cell lung cancer. , 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[10]  M. Mottolese,et al.  Technetium-99m-MIBI scintigraphy in the assessment of neoadjuvant chemotherapy in breast carcinoma. , 1997, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[11]  A Ciarmiello,et al.  Fractional retention of technetium-99m-sestamibi as an index of P-glycoprotein expression in untreated breast cancer patients. , 1997, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[12]  D. Piwnica-Worms,et al.  Pharmacokinetic modeling of multidrug resistance P-glycoprotein transport of gamma-emitting substrates. , 1997, The quarterly journal of nuclear medicine : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology.

[13]  D. Mankoff,et al.  Utility and reproducibility of semiquantitative analysis of sestamibi breast images. , 1997, Journal of nuclear medicine technology.

[14]  D Krebs,et al.  Technetium-99m-MIBI scintimammography for suspicious breast lesions. , 1996, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[15]  A. Robidoux,et al.  Technetium-99m-sestamibi prone scintimammography to detect primary breast cancer and axillary lymph node involvement. , 1995, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[16]  Thomas K. Lewellen,et al.  Investigation of the count rate performance of General Electric Advance positron emission tomograph , 1995 .

[17]  J. Ballinger,et al.  99Tcm‐sestamibi as an agent for imaging P‐glycoprotein-mediated multi‐drug resistance: In vitro and in vivo studies in a rat breast tumour cell line and its doxirubicin‐resistant variant , 1995, Nuclear medicine communications.

[18]  C. Stearns,et al.  Investigation of the count rate performance of the General Electric Advance positron emission tomograph , 1994, Proceedings of 1994 IEEE Nuclear Science Symposium - NSS'94.

[19]  C. Kao,et al.  Tc‐99m MIBI Uptake in Breast Carcinoma and Axillary Lymph Node Metastases , 1994, Clinical nuclear medicine.

[20]  I. Mena,et al.  Technical Aspects of Prone Dependent-Breast Scintimammography , 1994 .

[21]  T G Turkington,et al.  Performance characteristics of a whole-body PET scanner. , 1994, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[22]  I. Mena,et al.  Prone scintimammography in patients with suspicion of carcinoma of the breast. , 1994, Journal of the American College of Surgeons.

[23]  R. Kramer,et al.  Functional imaging of multidrug-resistant P-glycoprotein with an organotechnetium complex. , 1993, Cancer research.

[24]  A A Lammertsma,et al.  Measurements of blood flow and exchanging water space in breast tumors using positron emission tomography: a rapid and noninvasive dynamic method. , 1992, Cancer research.

[25]  U. Buell,et al.  Uptake kinetics of technetium-99m-methoxyisobutylisonitrile and thallium-201 in adult rat heart endothelial and fibroblast-like cells in comparison to myocytes. , 1992, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[26]  R K Jain,et al.  Haemodynamic and transport barriers to the treatment of solid tumours. , 1991, International journal of radiation biology.

[27]  J. Kronauge,et al.  Uptake and retention of hexakis (2-methoxyisobutyl isonitrile) technetium(I) in cultured chick myocardial cells. Mitochondrial and plasma membrane potential dependence. , 1990, Circulation.

[28]  Alun G. Jones,et al.  Uptake of the cation hexakis(2-methoxyisobutylisonitrile)-technetium-99m by human carcinoma cell lines in vitro. , 1990, Cancer research.

[29]  D. Berman,et al.  Technetium-99m hexakis 2-methoxyisobutyl isonitrile: human biodistribution, dosimetry, safety, and preliminary comparison to thallium-201 for myocardial perfusion imaging. , 1989, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[30]  E. Hoffman,et al.  Validation of PET-acquired input functions for cardiac studies. , 1988, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[31]  R. Okada,et al.  Myocardial kinetics of technetium-99m-hexakis-2-methoxy-2-methylpropyl-isonitrile. , 1988, Circulation.

[32]  J B Bassingthwaighte,et al.  Sensitivity functions in the estimation of parameters of cellular exchange. , 1984, Federation proceedings.

[33]  Terry Jones,et al.  POSITRON EMISSION TOMOGRAPHY FOR IN-VIVO MEASUREMENT OF REGIONAL BLOOD FLOW, OXYGEN UTILISATION, AND BLOOD VOLUME IN PATIENTS WITH BREAST CARCINOMA , 1984, The Lancet.

[34]  J. Kuikka,et al.  Regional blood flow in human tumours with special reference to the effect of radiotherapy. , 1976, The British journal of radiology.